Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 178,312 shares at $1.80 ($323K) on 2016-06-30, disclosed to the SEC on 2016-07-05.
Open-market sale of $323k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 300 | $540 | 0.2% |
| 2 | $1.80 | 15,200 | $27K | 8.5% |
| 3 | $1.80 | 300 | $541 | 0.2% |
| 4 | $1.80 | 300 | $542 | 0.2% |
| 5 | $1.81 | 300 | $543 | 0.2% |
| 6 | $1.82 | 3,350 |
| $6K |
| 1.9% |
| 7 | $1.80 | 44,841 | $81K | 25.0% |
| 8 | $1.80 | 100 | $180 | 0.1% |
| 9 | $1.80 | 200 | $360 | 0.1% |
| 10 | $1.80 | 3,200 | $6K | 1.8% |
| 11 | $1.80 | 3,200 | $6K | 1.8% |
| 12 | $1.80 | 200 | $360 | 0.1% |
| 13 | $1.80 | 100 | $180 | 0.1% |
| 14 | $1.80 | 11,350 | $20K | 6.3% |
| 15 | $1.81 | 11,350 | $21K | 6.4% |
| 16 | $1.81 | 200 | $362 | 0.1% |
| 17 | $1.81 | 25,800 | $47K | 14.4% |
| 18 | $1.81 | 7,362 | $13K | 4.1% |
| 19 | $1.81 | 7,362 | $13K | 4.1% |
| 20 | $1.81 | 200 | $362 | 0.1% |
| 21 | $1.81 | 4,300 | $8K | 2.4% |
| 22 | $1.82 | 4,300 | $8K | 2.4% |
| 23 | $1.82 | 13,830 | $25K | 7.8% |
| 24 | $1.82 | 1,400 | $3K | 0.8% |
| 25 | $1.83 | 1,400 | $3K | 0.8% |
| 26 | $1.83 | 700 | $1K | 0.4% |
| 27 | $1.85 | 3,617 | $7K | 2.1% |
| 28 | $1.85 | 100 | $186 | 0.1% |
| 29 | $1.86 | 100 | $186 | 0.1% |
| 30 | $1.86 | 5,900 | $11K | 3.4% |
| 31 | $1.86 | 1,400 | $3K | 0.8% |
| 32 | $1.87 | 1,700 | $3K | 1.0% |
| 33 | $1.87 | 1,400 | $3K | 0.8% |
| 34 | $1.88 | 2,550 | $5K | 1.5% |
| 35 | $1.90 | 100 | $190 | 0.1% |
| 36 | $1.91 | 300 | $573 | 0.2% |
| Total | $1.81 avg | 178,312 | $323K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |